Standards › ASF Health Standards v10 › Standard 51
Standard 51
Oncology and Cancer Care
Oncology and cancer care: safe handling of cytotoxic drugs, independent two-person checks, neutropenic fever treated quickly, extravasation managed at once, tumour board review, palliative care alongside treatment, and goals and wishes recorded..
Each criterion is shown in three settings: Humanitarian settings, Transition and fragile, and Standard. In standard settings, every criterion is Must.
Training colours: red means essential, green recommended, yellow optional. Each course shows its level for each setting: humanitarian, transition and fragile, and standard.
51.1Cytotoxic Drug Handling Follows a Verified Safe-Handling StandardHumanitarian settings: MustTransition and fragile: MustStandard: Must
Preparation, administration, and disposal of cytotoxic and other hazardous drugs follows a defined, verified safe-handling standard — appropriate personal protective equipment, engineering controls, and disposal procedures — not informal practice that varies by individual staff member, including on inpatient wards where chemotherapy may be administered outside the dedicated infusion unit.
Why it matters. Cytotoxic drugs can harm the people who prepare and give them, and the environment. A verified safe-handling standard for preparation, administration and disposal protects everyone.
How the surveyor verifies this criterion
Sample. Observe cytotoxic preparation, administration and disposal on several days, and review the verification register for the last 6 months.
1. Cytotoxic and hazardous drugs are handled under a defined, verified safe-handling standard.
Method. Compare the standard with the procedure for preparation, giving and disposal.
Evidence to show. Cytotoxic drug safe handling (ONC-SOP-001).
Pass when. The standard covers preparation, giving and disposal and is verified.
2. Protective equipment is worn for each task.
Method. Observe a sample of tasks and record the equipment worn.
Evidence to show. Cytotoxic handling verification register (ONC-REG-001).
Pass when. Equipment is worn for every observed task.
Immediate fail (any one means the criterion is not met). A nurse prepares a cytotoxic drug without gloves or a safety cabinet, and a spill exposes staff.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Cytotoxic drug safe handling | Must |
| Secretary (ISCO 3344) | Keeps the Cytotoxic handling verification register | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-001 · Cytotoxic drug safe handling | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-REG-001 · Cytotoxic handling verification register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 (National Institute for Occupational Safety and Health (CDC), 2024 (Publication 2025-103))
51.2Chemotherapy Dose Is Verified by Independent Two-Person CheckHumanitarian settings: MustTransition and fragile: MustStandard: Must
Every chemotherapy dose, drug, route, and infusion rate is independently verified by two qualified individuals before administration, each forming their own judgement separately — not a single check followed by a second signature, and applied identically on inpatient wards as in the dedicated oncology unit.
Why it matters. Chemotherapy doses are high and mistakes are severe. An independent second check by a second trained person catches the error before it reaches the patient.
How the surveyor verifies this criterion
Sample. Review every chemotherapy dose record for the last 3 months, and observe the check on several days.
1. Every chemotherapy dose is independently verified by two qualified people before administration.
Method. Check each sampled dose for two recorded independent checks made before administration.
Evidence to show. Chemotherapy two-person check record (ONC-FRM-002).
Pass when. Every sampled dose has two recorded independent checks before administration.
2. The check covers the drug, dose, route and infusion rate.
Method. Check the record for each element in the sample.
Evidence to show. Chemotherapy two-person check record (ONC-FRM-002).
Pass when. Every sampled check records all four elements.
Immediate fail (any one means the criterion is not met). A dose is checked by one nurse only, and an overdose is given because the second check was never made.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Chemotherapy independent two-person check (ONC-SOP-002); chemotherapy two-person check record | Must |
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-002 · Chemotherapy independent two-person check | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-FRM-002 · Chemotherapy two-person check record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- WHO (2021). Global Patient Safety Action Plan 2021–2030: Towards Eliminating Avoidable Harm in Health Care. Used for: Independent verification of high-risk medicines https://news.gmj.ge/guideline/global-patient-safety-action-plan-2021-2030-towards-eliminating-avoidable-harm-in-health-care/
51.3Neutropenic Fever Triggers an Immediate, Time-Bound ResponseHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
A patient with suspected neutropenic fever receives first-dose antibiotics within a defined, short time target from presentation, with staff trained to recognise the urgency and a protocol that bypasses routine triage queuing — not treated as a standard fever presentation.
Why it matters. Chemotherapy lowers the white cells that fight infection. A patient with fever in that state can die within hours. Giving antibiotics within a set time is what saves them.
How the surveyor verifies this criterion
Sample. Review every suspected neutropenic fever case in the last 12 months, against the time target and the register.
1. A patient with suspected neutropenic fever is treated as an emergency at triage.
Method. Check the triage record for each sampled case.
Evidence to show. Neutropenic fever response (ONC-SOP-003).
Pass when. Every sampled case is flagged as urgent at triage.
2. First-dose antibiotics are given within the time target.
Method. Compare the presentation and antibiotic times in the register with the target.
Evidence to show. Neutropenic fever time register (ONC-REG-002).
Pass when. Every sampled case had antibiotics within the target, or a recorded reason.
3. The time target is current against guidance.
Method. Check the target against the current guidance and the date of the last review.
Evidence to show. Neutropenic fever response (ONC-SOP-003).
Pass when. The target was reviewed within the last year.
Immediate fail (any one means the criterion is not met). A febrile neutropenic patient waits 4 hours for antibiotics in the waiting room, and no reason is recorded.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Neutropenic fever response (ONC-SOP-003); triage on arrival | Must |
| Secretary (ISCO 3344) | Keeps the Neutropenic fever time register (ONC-REG-002); sepsis recognition and antibiotic timing | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-003 · Neutropenic fever response | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-REG-002 · Neutropenic fever time register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- Management of febrile neutropaenia: ESMO Clinical Practice Guidelines (European Society for Medical Oncology, 2016)
51.4Extravasation Is Recognised and Managed ImmediatelyHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Staff administering vesicant or irritant chemotherapy agents are specifically trained to recognise early signs of extravasation, with a defined, immediate management protocol and appropriate antidotes available wherever these agents are administered, including inpatient wards.
Why it matters. If a drug that damages tissue leaks into the skin during an infusion, it can cause severe injury. Staff who recognise it early and act at once limit the harm.
How the surveyor verifies this criterion
Sample. Review extravasation events and staff training for chemotherapy giving, for the last 12 months.
1. A written immediate management protocol is followed at the first sign.
Method. Check each recorded extravasation for the protocol steps and times.
Evidence to show. Extravasation management record (ONC-FRM-003).
Pass when. Every recorded extravasation has the protocol started at once.
2. Antidotes and equipment are available at the chair.
Method. Check the chair kit on each sampled day.
Evidence to show. Extravasation recognition and immediate management (ONC-SOP-004).
Pass when. The kit is complete on every sampled day.
Immediate fail (any one means the criterion is not met). A vesicant leaks at the cannula, and the nurse continues the infusion for 10 minutes before stopping.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Extravasation recognition and immediate management (ONC-SOP-004); extravasation management record | Medium |
| Manager (ISCO 1342) | Maintains the Extravasation recognition and immediate management | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-004 · Extravasation recognition and immediate management | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-FRM-003 · Extravasation management record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- ONS/ASCO Guideline on the Management of Antineoplastic Extravasation (Oncology Nursing Society and American Society of Clinical Oncology, 2025)
51.5Multidisciplinary Tumour Board Informs Treatment PlanningHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Complex or newly diagnosed cancer cases are reviewed by a multidisciplinary tumour board before the treatment plan is finalised, with documented board input shaping the plan, not a single treating physician’s decision presented as though it were a team decision.
Why it matters. Complex cancer cases are best decided by a team of specialists together. A tumour board that reviews the case before treatment starts improves the decision.
How the surveyor verifies this criterion
Sample. Review the tumour board records for newly diagnosed and complex cases in the last 12 months.
1. Complex or newly diagnosed cases are reviewed by the board before the plan is finalised.
Method. Compare the list of eligible cases with the board records for the sample.
Evidence to show. Tumour board decision register (ONC-REG-003).
Pass when. Every eligible case in the sample has a board review before the plan.
2. The board includes the relevant specialties and records its input.
Method. Check each board record for the specialties present and the input recorded.
Evidence to show. Tumour board decision register (ONC-REG-003).
Pass when. Every board record lists the specialties and the input.
3. The board input is in the treatment plan.
Method. Check the plan for each reviewed case.
Evidence to show. Tumour board decision register (ONC-REG-003).
Pass when. Every reviewed case has the board input in its treatment plan.
Immediate fail (any one means the criterion is not met). A new breast cancer is started on surgery without a board review, and the board later recommends a different plan.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Secretary (ISCO 3344) | Keeps the Multidisciplinary tumour board (ONC-POL-001); tumour board decision register | Medium |
| Manager (ISCO 1342) | Checks the criterion at each review | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-REG-003 · Tumour board decision register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| ONC-POL-001 · Multidisciplinary tumour board | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
In process of development. Will be available soon.
51.6Palliative Care Integrated Alongside Active TreatmentHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Palliative care expertise is integrated early in the course of serious cancer diagnoses, alongside active treatment, not introduced only once active treatment has been exhausted — with symptom management and goals-of-care conversations happening throughout, not as a late, separate referral.
Why it matters. Cancer patients need palliative care alongside treatment, not only at the end. Bringing it in early controls symptoms and supports the patient through treatment.
How the surveyor verifies this criterion
Sample. Review the palliative care referrals and symptom records for patients with serious cancer diagnoses in the last 12 months.
Immediate fail (any one means the criterion is not met). A patient with metastatic disease gets no palliative input until the last week of life.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Checks the criterion at each review | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-005 · ONC-SOP-005 | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Oncology & Infusion Therapy Safety Endorsement (AMB-11) | Manager; Nurse |
References
- WHO (2021). Quality health services and palliative care: practical approaches and resources to support policy, strategy and practice. Used for: Palliative care alongside active treatment https://news.gmj.ge/guideline/quality-health-services-and-palliative-care-practical-approaches-and-resources-to-support-policy-strategy-and-practice/
- WHO (2019). Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Used for: Cancer pain management https://news.gmj.ge/guideline/guidelines-for-the-pharmacological-and-radiotherapeutic-management-of-cancer-pain-in-adults-and-adolescents/
51.7High-Alert Medicines Have Extra SafeguardsHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
A defined list of high-alert medicines applies on every ward. Each one has a second check, and concentrated electrolytes and insulin are kept separate from general stock.
Why it matters. High-alert medicines cause serious harm when given wrongly. An extra independent check and separate storage prevent the most common errors.
How the surveyor verifies this criterion
Sample. Check the high-alert medicine list, the storage of concentrated electrolytes and insulin, and the second-check records on several wards.
Immediate fail (any one means the criterion is not met). Concentrated potassium is stored with routine stock and is given in error.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-006 · ONC-SOP-006 | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-SOP-002 · Chemotherapy independent two-person check | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-FRM-002 · Chemotherapy two-person check record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Medication Safety: Operating SOP-MED-01 End to End (T-08) | Manager; Nurse |
References
- WHO (2021). Global Patient Safety Action Plan 2021–2030: Towards Eliminating Avoidable Harm in Health Care. Used for: High-alert medicines and medication safety https://news.gmj.ge/guideline/global-patient-safety-action-plan-2021-2030-towards-eliminating-avoidable-harm-in-health-care/
51.8Patients Are Triaged by UrgencyHumanitarian settings: MustTransition and fragile: MustStandard: Must
Every patient arriving for emergency or urgent care is sorted by clinical urgency, within a set time, using a recognised triage tool. The most urgent are seen first.
Why it matters. Triage decides who is seen first. Without a recognised tool, the sickest patient can wait behind the least sick, and nobody can show why.
How the surveyor verifies this criterion
Sample. Review triage records for a random sample of emergency and urgent arrivals in the last 3 months.
Immediate fail (any one means the criterion is not met). A patient with chest pain is triaged as non-urgent and waits 90 minutes.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-007 · ONC-SOP-007 | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Care & Treatment: Clinical Standards for Accreditation (H-04) | Manager; Nurse |
References
- WHO (2005). Emergency Triage Assessment and Treatment (ETAT): Manual for Participants. Used for: Triage by urgency https://news.gmj.ge/guideline/emergency-triage-assessment-and-treatment-etat-manual-for-participants/
51.9Sepsis Is Recognised and Treated QuicklyHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Staff recognise sepsis using a defined screening tool. Antibiotics are given within the time set by current sepsis guidelines, and the time is recorded.
Why it matters. Sepsis is time critical. Each hour of delay to antibiotics adds risk, so the time from recognition to treatment must be measured.
How the surveyor verifies this criterion
Sample. Review every suspected sepsis case in the sepsis register for the last 12 months.
Immediate fail (any one means the criterion is not met). A sepsis case is recognised at 9 am and antibiotics are given at 6 pm, with no record of the delay.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-008 · ONC-SOP-008 | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ONC-SOP-003 · Neutropenic fever response | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Safety & Emergency Preparedness (H-05) | Manager; Nurse |
References
- WHO (2024). WHO Guidelines on the Clinical Management of Sepsis (2024). Used for: Sepsis recognition and antibiotic timing
- NICE (n.d.). Suspected sepsis in people aged 16 or over: recognition, assessment and early management. Used for: Recognition of suspected sepsis https://news.gmj.ge/guideline/suspected-sepsis-in-people-aged-16-or-over-recognition-assessment-and-early-management/
- Surviving Sepsis Campaign (2021). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Used for: Sepsis management https://news.gmj.ge/guideline/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-septic-shock-2021/
51.10Pain and Symptoms Are Assessed and ControlledHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Pain and other symptoms (breathlessness, nausea, anxiety, agitation) are assessed on a schedule with a validated tool, and treated with a written symptom plan that is reviewed when symptoms change.
Why it matters. Pain and other symptoms such as breathlessness, nausea and agitation drive most of the suffering in serious illness. Assessing them on a schedule, and acting on the scores, is what keeps patients comfortable.
How the surveyor verifies this criterion
Sample. Review pain and symptom assessments and symptom plans for a sample of patients with cancer in the last 6 months.
Immediate fail (any one means the criterion is not met). A patient with severe nausea has no plan for 3 days, and the nausea is not reassessed.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-SOP-009 · ONC-SOP-009 | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Clinical & Medical Care in Long-Term Care (LTC-04) | Manager; Nurse |
References
- WHO (2019). Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Used for: Pain and symptom control https://news.gmj.ge/guideline/guidelines-for-the-pharmacological-and-radiotherapeutic-management-of-cancer-pain-in-adults-and-adolescents/
51.11The Patient’s Goals and Wishes Are RecordedHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
The patient’s goals, values and wishes are discussed and recorded, including advance directives, and are reviewed as the illness progresses.
Why it matters. Patients with serious illness have goals and wishes that shape their care. If they are not asked and written down, care is given according to what the team assumes they want.
How the surveyor verifies this criterion
Sample. Review patient goals and wishes records for patients with serious cancer in the last 12 months.
Immediate fail (any one means the criterion is not met). A patient with advanced cancer is never asked about goals, and an intensive procedure is started against their wishes.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ONC-FRM-004 · ONC-FRM-004 | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| End-of-Life & Palliative Care (LTC-06) | Manager; Nurse |
References
- WHO (2021). Quality health services and palliative care: practical approaches and resources to support policy, strategy and practice. Used for: Patient goals and advance care planning https://news.gmj.ge/guideline/quality-health-services-and-palliative-care-practical-approaches-and-resources-to-support-policy-strategy-and-practice/
Who is responsible for Standard 51
Each criterion names the positions responsible for it. Every position links to its own terms of reference.
Role details: reporting, supervision and training
Training shown is the general recommendation. Role-specific training is set in the next improvement round.
| Role | Reports to | Supervises | Recommended training |
|---|---|---|---|
| Consultant physician (internal medicine) | Head of department (per specialty) | Resident physician / house officer | Facility induction; safeguarding adults (general recommendation) |
| Oncologist (medical) | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Radiation oncologist | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Emergency physician | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Head nurse / ward manager | Director of nursing | Nurse specialist, Registered nurse, Nursing associate, Health care assistant / nursing aide | Facility induction; safeguarding adults (general recommendation) |
| Intensive care nurse | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Emergency nurse | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
| Social worker | Patient services manager | None | Facility induction; safeguarding adults (general recommendation) |
| Clinical pharmacist | Chief pharmacist | None | Facility induction; safeguarding adults (general recommendation) |
| Pharmacist (dispensing) | Chief pharmacist | None | Facility induction; safeguarding adults (general recommendation) |
| Head of emergency department | Medical director | Triage nurse, Emergency nurse | Facility induction; safeguarding adults (general recommendation) |
| Triage nurse | Head of emergency department | None | Facility induction; safeguarding adults (general recommendation) |
| Hospice / palliative care coordinator | Director of nursing | None | Facility induction; safeguarding adults (general recommendation) |
| Palliative care nurse | Head of department (per specialty) | None | Facility induction; safeguarding adults (general recommendation) |
Questions and answers
The criterion text is the authority. These answers summarise it.
Who does Standard 15 apply to?
Services that give cancer treatment, including chemotherapy and infusion units, and the emergency and ward teams that care for patients receiving it.
What do the colours mean for this standard?
Red (Must) is required. Green (Medium) is recommended. Yellow (Minimum) is the lowest acceptable level in humanitarian settings. Standard setting is Must on every criterion.
How are cytotoxic drugs handled?
Under 51.1 cytotoxic and hazardous drugs are prepared, given and disposed of under a verified safe-handling standard, with protective equipment and controls.
Is every chemotherapy dose checked?
Yes. Under 51.2 each chemotherapy dose, drug, route and rate is verified separately by two qualified people before it is given.
How fast is neutropenic fever treated?
Under 51.3 suspected neutropenic fever gets first-dose antibiotics within a defined short time from presentation.
What happens if a drug leaks into the tissue?
Under 51.4 staff are trained to recognise extravasation early and follow an immediate management protocol with antidotes.
Is treatment planned by a team?
Under 51.5 complex or new cancer cases are reviewed by a multidisciplinary tumour board before the plan is final.
When is palliative care offered?
Under 51.6 palliative care is integrated early, alongside active treatment, not only after it has ended.
Are high-alert medicines checked twice?
Yes. Under 51.7 a defined list of high-alert medicines has a second check, and concentrated electrolytes and insulin are kept separate.
How are patients triaged?
Under 51.8 every patient arriving for urgent care is sorted by clinical urgency within a set time, using a recognised tool.
How is sepsis recognised?
Under 51.9 sepsis is recognised with a defined screening tool, and antibiotics are given within the time set by current guidelines.
Are pain and symptoms controlled?
Under 51.10 pain and other symptoms are assessed on a schedule with a validated tool and treated with a written plan.
Are the patient’s wishes recorded?
Under 51.11 the patient’s goals, values and wishes, including advance directives, are recorded and reviewed as the illness progresses.
Guidelines for this standard
10 guideline(s) are held in the GMJ Guidelines Library and listed here. Each link opens the full guideline on news.gmj.ge. The complete library, grouped by standard, is at Guidelines.
- Managing Hazardous Drug Exposures: Information for Healthcare Settings (NIOSH / CDC)
- ONS/ASCO Guideline on the Management of Antineoplastic Extravasation (ONS/ASCO)
- NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 (NIOSH)
- Principles of Multidisciplinary Care (Cancer Australia)
- Management of Chemotherapy Extravasation: ESMO-EONS Clinical Practice Guidelines (European Society for Medical Oncology / European Oncology Nursing Society)
- Management of Febrile Neutropaenia: ESMO Clinical Practice Guidelines (European Society for Medical Oncology)
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 (National Institute for Occupational Safety and Health / CDC)
- Guide to Cancer Early Diagnosis (WHO)
- Guideline for Preventive Chemotherapy for the Control of Taenia solium Taeniasis (Pan American Health Organization)
- Guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever (World Health Organization)
Also relevant to this standard:
- Suspected Cancer: Recognition and Referral (NICE NG12) (NICE)
- Suspected cancer: recognition and referral (NG12) — safety netting (NICE)
- Pain — Clinical guidelines — Diagnosis and treatment manual — MSF Clinical guidelines (Médecins Sans Frontières)
- Fever — MSF Clinical guidelines (Médecins Sans Frontières)
- Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents (World Health Organization)
- Suspected sepsis in under 16s: recognition, diagnosis and early management (NG254) (National Institute for Health and Care Excellence (UK))
- Suspected sepsis in people aged 16 or over: recognition, assessment and early management (National Institute for Health and Care Excellence (UK))